Clinical Trial Update: Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

View source ↗

Summary

This clinical trial update describes the development of patient-reported outcome measures to assess tumor visibility and appearance concerns in Neurofibromatosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibroma
• Neurofibromatosis Type

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis Type 1, Neurofibroma | Status: RECRUITING